Category Archives for "Patient Safety"

Apr 01

Zantac ordered off the shelves by FDA due to Cancer causing NDMA

By Joe Messa

The U.S. Food and Drug Administration (FDA) issued a press release today requesting that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This comes months after the FDA announced its initial warning regarding ranitidine medications (brand name ZANTAC) and the possible presence of a contaminant known as N-Nitrosodimethylamine (NDMA). NDMA […]

Continue reading
Aug 05

New Jersey Politicians Attempt to Control where New Jersey Patients can Receive Medical Treatment with Bipartisan ‘Patient Protection Act’

By Joe Messa

A bill currently moving through the New Jersey legislature aims to seriously limit physicians’ choices when it comes to the treatment of their patients. The bill (S-3816/A-5369), called the ‘Patient Protection Act,’ imposes lengthy, time-consuming processes on physicians who want to transfer or refer patients to out-of-state medical providers. The bill claims to protect patients […]

Continue reading
Dec 06

RECALL: Infant Ibuprofen sold at Walmart, CVS, and Family Dollar

By Joe Messa

Tris Pharma, Inc., a New Jersey based pharmaceutical manufacturer, has issued a voluntary recall of infant ibuprofen that may contain higher concentrations than noted on the bottle, leading to potential risks in infants. The impacted lots of medication were sold to a distributor that supplies retailers, including CVS, Walmart, and Family Dollar. Retailers and wholesalers […]

Continue reading